Case Study: Metacrine streamlines Series B due diligence with ShareVault

Metacrine uses ShareVault to Communicate Due Diligence Data with Multiple Venture Capitalist Companies

Metacrine, a life‑sciences company developing therapies for metabolic diseases such as type 2 diabetes and NASH, needed a better way to share sensitive due diligence materials for its Series B fundraising. The company had previously relied on time‑consuming roadshows and on‑site computer setups, lacking a central online repository, visibility into investor activity, and control over documents once shared.

Metacrine adopted ShareVault as a secure virtual data room to organize and share materials with multiple venture capital firms simultaneously. The solution reduced travel and resource costs, provided granular permissions and revocable access, and gave clear insight into who viewed which documents and for how long—enabling efficient, global, and trackable due diligence with ten VC firms.

Metacrine

Eric Bischoff

VP of Business Operations